Heidelberg (pta045/05.10.2020/16:16) - Announcement
1 | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | David Roth |
2 | Reason for the notification | |
a) | Position/status | Member of the managing body |
b) | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | 4basebio AG |
b) | LEI | 391200H5BDEVHMOV3U10 |
4 | Details of the transaction(s) | |
a) | Description of the financial instrument, type of instrument | Share |
Identification code | DE000A2YN801 | |
b) | Nature of the transaction | Sale |
c) | Price(s) | Volume(s) |
2.00 EUR | 339,000.00 EUR | |
d) | Aggregated price | Aggregated volume |
2.00 EUR | 339,000.00 EUR | |
e) | Date of the transaction | 30.09.2020 UTC+2 |
f) | Place of the transaction | Outside a trading venue |
5 | Explanation | |
Sale as part of the takeover bid by Sparta AG. |
emitter: | 4basebio AG Waldhofer Str. 102 69123 Heidelberg Germany |
contact person: | Robert Mayer |
phone: | +49 171 3876540 |
e-mail: | robert.mayer@4basebio.com |
website: | investors.4basebio.com |
stock exchanges: | regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate |
ISIN(s): | DE000A2YN801 (share) |